Lexpos News

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Sodium fusidate (Fucidin®) 250mg tablets and fusidic acid (Fucidin®) 250mg/5ml oral suspension MSN/2024/107 Tier 2 medium impact Date of issue: 7th October 2024 Sodium fusidate (Fucidin®) 250mg tablets will be discontinued from mid-January 2025. Fusidic acid (Fucidin®) 250mg/5ml oral suspension will [...]

The post Medicine Supply Notification: Sodium fusidate (Fucidin® ) 250mg tablets and fusidic acid (Fucidin® ) 250mg/5ml oral suspension appeared first on Community Pharmacy England.

LPCs and Community Pharmacy England met with a range of advocates and patient groups last week to reflect on the outlook for the sector a year on from the publication of the Vision for Community Pharmacy. The Annual Conference of LPCs and Community Pharmacy England held last Thursday focussed on crucial considerations for the coming year, [...]

The post One Year on from Vision: LPCs and wider stakeholders consider the outlook for pharmacy appeared first on Community Pharmacy England.

NHS England will be relaunching their Pharmacy First public-facing campaign on Monday 11th October 2024. Minor revisions have been made to the original campaign materials used earlier this year, including additional information on the age criteria for the clinical pathways. Ahead of the official launch, the campaign materials are available on the Department of Health [...]

The post NHS England Pharmacy First campaign to re-start on Monday appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Nyzamac® SR 60mg capsules is now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP076 Nyzamac® SR 60mg capsules expires at 23.59pm on Friday 8 November 2024. After this date, any prescriptions for Nyzamac® SR 60mg [...]

The post Expiry of SSP076 Nyzamac® SR 60mg capsules appeared first on Community Pharmacy England.

The Government has made The Medicines (Gonadotrophin-Releasing Hormone Analogues) (Emergency Prohibition) (Extension) (No. 2) Order 2024, which has the effect of extending the ban, which was due to expire. The ban has been extended until 31 December 2024. The Secretary of State has expressed the intention to make the ban permanent, but can only do [...]

The post Legislation restricting the sale and supply of gonadotrophin-releasing hormone analogues further extended appeared first on Community Pharmacy England.